Postdoctoral Position in Pharmacometrics, Multi-omics, and Precision Therapeutics for Pediatric IBD Stanford University in United States

Stanford University School of Medicine is advertising an open postdoctoral position in the Precision Therapeutics for IBD (Colman Lab) led by Ruben Colman. The project focuses on pharmacometrics, clinical pharmacology, and multi-omics approaches for improving treatment outcomes in children with inflammatory bowel disease (IBD).

The postdoctoral scholar will work with an interdisciplinary team spanning clinical pharmacology, microbiome research, metabolomics, and computational analysis. The lab emphasizes precision dosing, PK/PD modeling, model-informed precision dosing, and AI/ML-assisted translational medicine. Research interests mentioned include integrating microbial biomarkers and other omics data to overcome the therapeutic ceiling in pediatric IBD.

Eligibility: applicants must hold a PhD, PharmD, MD, or DO (or equivalent). Strong experience in pharmacometrics or bioinformatics/omics analysis is preferred, along with quantitative modeling skills in R and/or Python. Experience with NONMEM, PK modeling, reproducible workflows, and multi-omics datasets such as metagenomics, metabolomics, or proteomics is desirable.

Funding: the appointment is fixed term for one year with opportunity for renewal. The expected base pay is the Stanford required minimum for postdoctoral scholars; the FY27 minimum is $79,056.

How to apply: submit a single combined PDF with a letter of interest and research summary, CV/resume, and three references. Email the application materials to [email protected] and cc [email protected]. The post links to Stanford’s application portal and the Colman Lab website for more information.